Abstract
The objective of this study was to examine interindividual variability in codeine requirements and pain management by examining select genetic polymorphisms in the codeine pharmacological pathway. The study included a nested cohort of 98 women who were prescribed codeine following cesarean section. Participants were genotyped for select polymorphisms of the COMT, ABCB1, CYP2D6, UGT2B7 and OPRM1 genes and instructed to describe their level of pain using the visual analog scale (mm) 1 h following each dose of codeine. Analysis revealed that reported pain increases with maternal age (P=0.041). Asians required more codeine than Caucasians (P=0.048). Significant differences in mean dose consumption were seen among the genotypic groups of the OPRM1 A118G (P=0.001) and UGT2B7 C802T (P=0.015) variants. These variants were found to predict codeine consumption in the cohort overall (P=0.000) and among Caucasians (P=0.001). These findings will assist in customizing therapy to effectively manage postpartum pain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Peter EA, Janssen PA, Grange CS, Douglas MJ . Ibuprofen versus acetaminophen with codeine for the relief of perineal pain after childbirth: a randomized controlled trial. CMAJ 2001; 165: 1203–1209.
Lötsch J, Rohrbacher M, Schmidt H, Doehring A, Brockmöller J, Geisslinger G . Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation? Pain 2009; 144: 119–124.
Madadi P, Shirazi F, Walter FG, Koren G . Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr Drugs 2008; 10: 399–404.
Willmann S, Edginton AN, Coboeken K, Ahr G, Lippert J . Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study. Clin Pharmacol Ther 2009; 86: 634–643.
Fagerlund TH, Braaten O . No pain relief from codeine...? An introduction to pharmacogenomics. Acta Anaesthesiol Scand 2001; 45: 140–149.
Sindrup SH, Brøsen K . The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 1995; 5: 335–346.
Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med 2004; 351: 2827–2831.
Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 2008; 109: 520–526.
Tan EC, Lim EC, Teo YY, Lim Y, Law HY, Sia AT . Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 2009; 5: 32.
Smith HS . Opioid metabolism. Mayo Clin Proc 2009; 7: 613–624.
Sawyer MB, Innocenti F, Das S, Cheng C, Ramírez J, Pantle-Fisher FH et al. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 2003; 73: 566–574.
Portenoy RK, Thaler HT, Inturrisi CE, Friedlander-Klar H, Foley KM . The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther 1992; 51: 422–431.
Campa D, Gioia A, Tomei A, Poli P, Barale R . Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 2008; 83: 559–566.
Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A et al. Functional polymorphisms of the human multi-drug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–3478.
Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M et al. Pharmacokinetic modeling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol 2002; 54: 592–603.
Lee PJ, Delaney P, Keogh J, Sleeman D, Shorten GD . Catecholamine-o-methyltransferase polymorphisms are associated with postoperative pain intensity. Clin J Pain 2011; 27: 93–101.
Dai F, Belfer I, Schwartz CE, Banco R, Martha JF, Tighioughart H et al. Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J 2010; 10: 949–957.
Rakvåg TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S et al. The Val158Met polymorphism of the human catechol-O -methyltransferase (COMT gene may influence morphine requirements in cancer pain patients. Pain 2005; 116: 73–78.
Kelly LE, Chaudhry SA, Rieder MJ, ‘t Jong G, Moretti ME, Lausman A et al. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk. PLoS One 2013; 8: e70073.
Vandervaart S, Berger H, Tam C, Goh YI, Gijsen VM, de Wildt SN et al. The effect of distant reiki on pain in women after elective Caesarean section: a double-blinded randomized controlled trial. BMJ Open 2011; 1: e000021.
VanderVaart S, Berger H, Sistonen J, Madadi P, Matok I, Gijsen VM et al. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. Ther Drug Monit 2011; 33: 425–432.
Bellville JW, Forres WH Jr, Miller E, Brown BW Jr . Influence of age on pain relief from analgesics. A study of postoperative patients. JAMA 1971; 217: 1835–1841.
Janicki PK, Schuler G, Francis D, Bohr A, Gordin V, Jarzembowski T et al. A genetic association study of the functional A118G polymorphism of human mu-opioid receptor gene in patients with acute and chronic pain. Anesth Analg 2006; 103: 1011–1017.
Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, Trégouet D et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther 2006; 79: 316–324.
Mahmoud S, Thorsell A, Sommer WH, Heilig M, Holgate K, Bartlett SE et al. Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca2+ channels in humanized mouse sensory neurons. Anesthesiology 2011; 115: 1054–1062.
Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W . Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 230: 32618–32624.
Holthe M, Rakvåg TN, Klepstad P, Idle JR, Kaasa S, Krokan HE et al. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics 2003; 3: 17–26.
Lötsch J, Kobal G, Stockmann A, Brune K, Geisslinger G . Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology 1997; 87: 1348–1358.
Carnie JC, Perks D . The pattern of postoperative analgesic administration in non-English speaking Asian women following caesarean section. Ann R Coll Surg Engl 1984; 66: 365–366.
Houghton IT, Aun CS, Gin T, Lau JT . Inter-ethnic differences in postoperative pethidine requirements. Anaesth Intensive Care 1992; 20: 52–55.
Konstantatos AH, Imberger G, Angliss M, Cheng CH, Meng AZ, Chan MT . A prospective cohort study comparing early opioid requirement between Chinese from Hong Kong and Caucasian Australians after major abdominal surgery. Br J Anaesth 2012; 109: 797–803.
Sadhasivam S, Chidambaran V . Pharmacogenomics of opioids and perioperative pain management. Pharmacogenomics 2012; 13: 1719–1740.
Lampe JW, Bigler J, Bush AC, Potter JD . Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 2000; 9: 329–333.
Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther 2012; 91: 321–326.
Madadi P, Koren G . Pharmacogenomics principles: introduction to personalized medicine. In: Langman LJ, Dasgupta A (eds). Pharmacogenomics in Clinical Therapeutics. John Wiley & Sons Ltd: Chichester, 2012, pp 1–14.
Kim K-M, Kim H-K, Lim SH, Cheong SH, Choi E-J, Kang H et al. Effect of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Koren gynecological patients. Int J Clin Pharmacol Ther 2013; 51: 383–392.
Yang JC, Clark WC, Tsui SL, Ng KF, Bennett CS . Preoperative multidimensional affect and pain survey (MAPS) scores predict postcolectomy analgesia requirement. Clin J Pain 2000; 16: 314–320.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
CR, CB and GK are supported by grants from the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), Genome British Columbia and the Child & Family Research Institute (CFRI). MB has been awarded a University of Toronto Fellowship Award.
Additional information
Disclaimer
The sponsors have no role in the design of this study; collection, analysis and interpretation of the data; writing of this manuscript or the decision to submit this manuscript for publication. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest/conflict in the subject matter. No writing assistance was utilized in the production of this manuscript.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Baber, M., Chaudhry, S., Kelly, L. et al. The pharmacogenetics of codeine pain relief in the postpartum period. Pharmacogenomics J 15, 430–435 (2015). https://doi.org/10.1038/tpj.2015.3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2015.3